David Vanderveen
Known title: DirectorCIK: 0001167191
Associated companies
Transaction History
| PRE | ▲ Buy | Option Exercise | 6,944 | $0 | 6/15/2026 | View on chart |
| PRE | ▲ Buy | Option Exercise | 6,944 | $0 | 6/15/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Prenetics Global Releases Q2 2026 Earnings Call Transcript
Prenetics Global has published the full transcript of its Q2 2026 earnings call. The transcript provides details on the company’s financial performance, guidance, and strategic initiatives. Investors can review the discussion to better understand the company’s outlook. The release follows the company’s recent earnings announcement.
Prenetics Global Releases Q2 2026 Earnings Call Transcript. Prenetics Global has published the full transcript of its Q2 2026 earnings call. The transcript provides details on the company’s financial performance, guidance, and strategic initiatives. Investors can review the discussion to better understand the company’s outlook. The release follows the company’s recent earnings announcement.